Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Change in Cash (2020 - 2025)

Vivos Therapeutics has reported Change in Cash over the past 6 years, most recently at -$1.1 million for Q4 2025.

  • Quarterly Change in Cash fell 1974.51% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.2 million through Dec 2025, down 191.64% year-over-year, with the annual reading at -$4.2 million for FY2025, 191.64% down from the prior year.
  • Change in Cash was -$1.1 million for Q4 2025 at Vivos Therapeutics, up from -$1.3 million in the prior quarter.
  • Over five years, Change in Cash peaked at $20.1 million in Q2 2021 and troughed at -$6.2 million in Q1 2022.
  • The 5-year median for Change in Cash is -$2.1 million (2023), against an average of -$808850.0.
  • Year-over-year, Change in Cash skyrocketed 6463.13% in 2021 and then crashed 1974.51% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$4.5 million in 2021, then increased by 28.95% to -$3.2 million in 2022, then soared by 120.47% to $655000.0 in 2023, then crashed by 107.79% to -$51000.0 in 2024, then crashed by 1974.51% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Change in Cash are -$1.1 million (Q4 2025), -$1.3 million (Q3 2025), and $2.1 million (Q2 2025).